Aedh Abdullah Ibrahim
Department of Internal Medicine, College of Medicine, Najran University, Najran 1988, Saudi Arabia.
World J Clin Cases. 2022 Aug 26;10(24):8755-8760. doi: 10.12998/wjcc.v10.i24.8755.
Cardiac arrhythmias, including bradyarrhythmias, have been described as manifestations of coronavirus disease 2019 (COVID-19). Herein, we present a case of junctional bradycardia secondary to possible sinus node dysfunction in a patient with COVID-19.
The patient was a 32-year-old woman with no significant medical history. On the third day of hospitalization, she developed junctional bradycardia while being hemodynamically stable. The episodes of nodal dysrhythmia with a low heart rate persisted for the next few days and were associated with elevated levels of systemic inflammatory markers. The patient received antiviral and anti-inflammatory treatments for the viral infection but no antiarrhythmic medications. She had a normal sinus rhythm on day 12.
Cardiac rhythm monitoring, focusing on the association between cardiac arrhythmias and the systemic inflammatory response, is important in COVID-19 patients.
心律失常,包括缓慢性心律失常,已被描述为2019冠状病毒病(COVID-19)的表现。在此,我们报告一例COVID-19患者因可能的窦房结功能障碍继发交界性心动过缓的病例。
患者为一名32岁女性,无重大病史。住院第三天,她在血流动力学稳定的情况下出现交界性心动过缓。接下来的几天里,心率较低的结性心律失常持续存在,并与全身炎症标志物水平升高有关。患者因病毒感染接受了抗病毒和抗炎治疗,但未使用抗心律失常药物。第12天时她恢复了正常窦性心律。
在COVID-19患者中,关注心律失常与全身炎症反应之间的关联进行心律监测很重要。